Article ID Journal Published Year Pages File Type
2540238 International Immunopharmacology 2016 6 Pages PDF
Abstract

•MCP-1 RNAi inhibited cytokine expression in microglia and attenuated neuron injury.•MCP-1 might promote ICH induced microglia activation and toxicity to neuron.•MCP-1 RNAi might provide promising therapeutical strategy for ICH.

Microglia are activated after intracerebral hemorrhage and induce neuron death by releasing proinflammatory cytokines and chemokines. However, the related mechanism of microglia activation in such conditions remains elusive. MCP-1, the ligand of CCR2 expressed in the central nervous system, could promote microglia proliferation, survival and cytokine secretion. According to the previous findings, we make a hypothesis that whether alternation of MCP-1 level could attenuate microglia activation and toxicity to neuron in intracerebral hemorrhage. To identify that, we interfere with the MCP-1 expression of microglia by RNAi technology, and coculture the microglia and neuron in ICH. The results demonstrated that MCP-1 RNAi inhibited TNF-α, IL-1β and IL-6 expression in microglia and attenuated neuron injury. In conclusion, the present study suggests that MCP-1 might promote ICH induced microglia activation and toxicity to neuron, and MCP-1 RNAi might provide promising therapeutical strategy for ICH.

Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , ,